Synthetic ligands targeting Rev-Erbα, such as SR9009, have the ability to modulate lung clock function and improve respiratory function and inflammation in individuals with asthma and COPD [36]. The gene discussed is CLOCK; the disease is chronic obstructive pulmonary disease.